The European Commission Chief Spokesperson Eric Mamer rebuffed criticism of the slow uptake of vaccines across the EU, since the authorization of the BioNTech vaccine at...
On 17 November, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses...
In a statement this afternoon (16 November), President of the European Commission Ursula von der Leyen, announced that the European Commission has reached a new agreement...
With the first half of 2020 having been heavily impacted by the COVID-19 pandemic, the virus finally seems to be in retreat – at least in a handful...
Today (16 March) the European Commission Chief Spokesperson Eric Mamer announced that the President of the European Commission Ursula von der Leyen and the President of...
Germany’s CureVac, among the vaccine developers funded by the Coalition for Epidemic Preparedness Innovations (CEPI), said it could mass-produce a coronavirus immunization from its existing facilities...